ImmunoGen, Inc. Company Information
ImmunoGen, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: ImmunoGen, Inc.
- Ticker: 0A8K
- Exchange: LSE
- Founded: 1980
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$8.359b
- Shares Outstanding: 267.66m
- Website: https://www.immunogen.com
Number of Employees
Location
- ImmunoGen, Inc.
- 830 Winter Street
- Waltham
- Massachusetts
- 02451-1477
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IMGN | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Nov 1989 |
| IMU | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Nov 1989 |
| IMU | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Nov 1989 |
| IMGN * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Nov 1989 |
| 0A8K | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Nov 1989 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/12 05:14 |
| End of Day Share Price | 2024/02/12 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.